NC
HSTO

Northpointe Capital’s Histogen Inc. Common Stock HSTO Stock Holding History

Northpointe Capital’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-358
Closed -$438K – 268
2014
Q3 		$438K Sell
358
-170
-32% -$244K 0.05% 236
2014
Q2 		$962K Buy
+528
New +$705K 0.09% 218

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Northpointe Capital's HSTO Position: Q4 2014 in Review

Northpointe Capital sold out of Histogen Inc. Common Stock (HSTO) in Q4 2014, closing a stake of 358 shares — an estimated $438K sold.

Northpointe Capital first reported a position in HSTO in Q2 2014 and held it in 2 quarters. The position peaked at $962K in Q2 2014. 36 funds tracked by Wall St. Rank hold HSTO as of Q4 2014.

  • Northpointe Capital reported no remaining Histogen Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Northpointe Capital sold 358 Histogen Inc. Common Stock shares in Q4 2014, an estimated $438K.
  • Northpointe Capital first reported a position in Histogen Inc. Common Stock in Q2 2014 and held it in 2 quarters.
  • Northpointe Capital's Histogen Inc. Common Stock position peaked at $962K in Q2 2014.
  • 36 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2014.

Based on Northpointe Capital's 13F filing for Q4 2014, filed 26 Jan 2015.